An easy and practical guide for imaging infection/inflammation by [18F]FDG PET/CT

[1] Sollini M(2018)Current status of molecular imaging in infections Curr Pharm Des 24 754-771

[2] Lauri C(2018)Current status of molecular imaging in inflammatory and autoimmune disorders Curr Pharm Des 24 743-753

[3] Boni R(2016)Imaging bacteria with radiolabelled quinolones, cephalosporins and siderophores for imaging infection: a systematic review Clin Transl Imaging 4 229-252

[4] Lazzeri E(2019)PET radiopharmaceuticals for specific bacteria imaging: a systematic review J Clin Med 8 197-139

[5] Erba PA(2018)Validation of 2–18F-fluorodeoxysorbitol as a potential radiopharmaceutical for imaging bacterial infection in the lung J Nucl Med 59 134-787

[6] Signore A(2016)Biodistribution and radiation dosimetry of the enterobacteriaceae-specific imaging probe [(18)F]fluorodeoxysorbitol determined by PET/CT in healthy human volunteers Mol Imaging Biol 18 782-214

[7] Signore A(2016)Infection imaging with (18)F-FDS and first-in-human evaluation Nucl Med Biol 43 206-213

[8] Anzola KL(2014)Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography Sci Transl Med. 6 259ra146-436

[9] Auletta S(2015)SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade Q J Nucl Med Mol Imaging 59 197-316

[10] Varani M(2019)Antibody-based tracers for PET/SPECT imaging of chronic inflammatory diseases ChemBioChem 20 422-487

[1] Sollini M(2018)Current status of molecular imaging in infections Curr Pharm Des 24 754-771

[2] Lauri C(2018)Current status of molecular imaging in inflammatory and autoimmune disorders Curr Pharm Des 24 743-753

[3] Boni R(2016)Imaging bacteria with radiolabelled quinolones, cephalosporins and siderophores for imaging infection: a systematic review Clin Transl Imaging 4 229-252

[4] Lazzeri E(2019)PET radiopharmaceuticals for specific bacteria imaging: a systematic review J Clin Med 8 197-139

[5] Erba PA(2018)Validation of 2–18F-fluorodeoxysorbitol as a potential radiopharmaceutical for imaging bacterial infection in the lung J Nucl Med 59 134-787

[6] Signore A(2016)Biodistribution and radiation dosimetry of the enterobacteriaceae-specific imaging probe [(18)F]fluorodeoxysorbitol determined by PET/CT in healthy human volunteers Mol Imaging Biol 18 782-214

[7] Signore A(2016)Infection imaging with (18)F-FDS and first-in-human evaluation Nucl Med Biol 43 206-213

[8] Anzola KL(2014)Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography Sci Transl Med. 6 259ra146-436

[9] Auletta S(2015)SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade Q J Nucl Med Mol Imaging 59 197-316

[10] Varani M(2019)Antibody-based tracers for PET/SPECT imaging of chronic inflammatory diseases ChemBioChem 20 422-487